Navigation Links
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
Date:2/7/2008

GAITHERSBURG, Md., Feb. 7 /PRNewswire/ -- MedImmune today announced that it has strengthened its leadership in research, human resources (HR) and regulatory affairs with three key promotions and has also hired a new head of vaccine manufacturing. Peter A. Kiener, D. Phil. has been appointed to executive vice president, research; Katy Strei to vice president, people and organization development, HR; and Eileen Valenta to vice president, operations and compliance, regulatory affairs. In addition, Shou-Bai Chao, Ph.D. has recently joined the company as vice president of vaccine manufacturing.

"As MedImmune prepares for the next phase of its corporate growth -- including dramatic acceleration within its product portfolio, it is imperative that we have strong leadership at the helm of all aspects of our business, but particularly within the research, HR and regulatory affairs functions," said David M. Mott, chief executive officer and president.

"Peter is now driving forward our global research efforts, which span from our core antibody research center in Maryland's biotech corridor to our discovery and development center in Cambridge, UK to our vaccine research facilities in the San Francisco Bay area of California. Katy is ensuring that we have the right people -- with the right skills -- at the right time, which is critical for us to deliver on the promise of our pipeline. Eileen's contributions will grow significantly with our maturing product portfolio and its need for regulatory affairs and compliance oversight. And, as we carry forward the potential next-generation of innovative vaccines, Shou-Bai is a welcome addition to the organization," Mott added.

Management Promotions

Dr. Peter Kiener has been promoted from senior vice president, research to executive vice president, research, overseeing all global research activities for the company. Since joining MedImmune in 2001, Dr. Kiener has made expert and strategic contributions in
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. MedImmune Submits Biologics License Application to FDA for Motavizumab
2. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
3. MedImmune Announces Seven Key Promotions and New Hires
4. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
5. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
6. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
7. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
8. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
9. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
10. Anavex strengthens Board of Directors
11. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ation of ultrasmall transistors and more powerful ...nducting nanowires are closer to reality after a k...ity and the University of California at Los Angele...nanowires with layers of different materials that ...a critical requirement for making efficient transi...
(Date:11/25/2009)...CA RATON, Fla., Nov. 25 For many b...r BodyLogicMD. The nation,s largest and fastest g...xclusively in medically supervised bioidentical h... its network since November 2008 - from 21 to 3...sician-owned centers, including one in Puerto Rico...
(Date:11/25/2009)...ire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq:...m.D., president and chief executive officer, will ...re Conference. , ,Presentation details are as fol...rence,Date: Tuesday, December 1, 2009,Time: ... Palace Hotel, New York, NY,Webcast: <a href=,h...
(Date:11/24/2009)...nvestment bank KTA Capital,s client Neuren Pharmac...nvertible note private placement with a U.S. insti...ged by KTA Capital as Neuren,s exclusive placement... York (PRWEB) November 23, 2009 -- The independent...KTA Capital") has announced that its client N...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
..., a 7% increase over last year,s first , quarte...over-year , - Record pre-tax income of $15.4 mill... of 12% over last year,s , first quarter , - ... a variety of , categories , - Improvements i... , leverage in our business , , COLUMBIA, Md.,...
...ech, Inc. scientists, Drs. Loretta Mayer, Cheryl D...hird International Workshop on Fertility Control i...e they presented SenesTech,s latest developments i...ation only meeting is organized by the governments...Great Britain, who are working together to support...
...chnologies announced today that David E. Kandzari,...ymer DES System" during the Cardiovascular Researc... March 5, 2009. MiStent(TM), a Drug-Eluting Stent ...able polymer coating that delivers the potential b...e proprietary formulation allows the polymer to be...
Other Biology Technology:Martek Announces First Quarter 2009 Financial Results 2Martek Announces First Quarter 2009 Financial Results 3Martek Announces First Quarter 2009 Financial Results 4Martek Announces First Quarter 2009 Financial Results 5Martek Announces First Quarter 2009 Financial Results 6Martek Announces First Quarter 2009 Financial Results 7Martek Announces First Quarter 2009 Financial Results 8Martek Announces First Quarter 2009 Financial Results 9Martek Announces First Quarter 2009 Financial Results 10SenesTech Scientists Attend International Workshop on Fertility in New Zealand 2Micell Technologies' Rapid Absorption Polymer DES System to be Presented at CRT 2009 2
(Date:11/26/2009)..., Ecologists have at last worked out a way of usi...e size of bird populations. This is the first time...n translated into accurate estimates of bird speci...ed in the British Ecological Society,s Journal of... it could lead to a major advance in our ability t...
(Date:11/26/2009)..., , Heidelberg, 27 November 2009 What are the ...ents required to produce a cell that can survive o...f a cell, and understand how an entire organism fu...estions that scientists in a partnership between t... Heidelberg, Germany, and the Centre de Regulacio ...
(Date:11/25/2009)..., Ghrelin, a hormone produced in the stomach, may...lopment of Parkinson,s disease, Yale School of Med... recent issue of the Journal of Neuroscience . ,...of dopamine neurons in an area of the midbrain kno...or dopamine production. Reduced production of dop...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Elsevier announces 2008 journal impact factor highlights 9040 1Elsevier announces 2008 journal impact factor highlights 9040 2Elsevier announces 2008 journal impact factor highlights 9040 3Jeff Stewart Joins Decision Resources Inc as Chief Information Officer 50277 1Jeff Stewart Joins Decision Resources Inc as Chief Information Officer 50277 2DuoCort 3A New chronotherapy for adrenal insufficiency 9039 1DuoCort 3A New chronotherapy for adrenal insufficiency 9039 2DuoCort 3A New chronotherapy for adrenal insufficiency 9039 3
...d chimpanzees in Uganda have discovered repeated i...avior: female-led infanticide. The findings, repor...es of the University of St. Andrews, Scotland, and... May 15th issue of the journal Current Biology, pu...ccur in many primate species, but is generally tho...
...rsity of California-Davis recently developed a mat... bacteria in the environment. Researchers believe ...king into account characteristics of the natural s...uts. This model will help scientists to quantify t...pping of genetic material between bacteria leads t...
...sity of Warwick have found that the standard Briti...mages the anticancer properties of many Brassica v...flower and green cabbage. , Past studies have show...s the risk of cancer. This is because of the high ...glucosinolates which are metabolized to cancer pre...
Other Biology News:Female-led infanticide in wild chimpanzees 2Researchers develop way to calculate speed of bacterial sex 2Research says boiling broccoli ruins its anti-cancer properties 2
Cynomolgus macaque serum from Alpha Genesis, Inc.
Anti-Foam Reagent from Promega
Rat Tissue Array: Brain, heart, kidney, liver, lung, muscle, spleen and stomach, each tissue from 10 female and 10 male, respectively from BioChain
EPH electrode, anode from GE Healthcare, formerly Amersham Biosciences
Biology Products: